Institutional investors hold a majority ownership of PBH through the 104.13% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2017, these large investors purchased a net $1.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 696.1 Thousand shares of Prestige Brands Holdings ...